Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Saag

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Epidemiology (Cambridge, Mass.)|June 17, 2020
Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of DeathTiffany L Breger, Jessie K Edwards, Stephen R Cole, et al.
The Journal of Infectious Diseases|May 13, 2009
A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1Michael Saag, James Goodrich, Gerd Fätkenheuer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patientsDonald P Kotler, Norma Muurahainen, Carl Grunfeld, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Fat distribution in men with HIV infectionPeter Bacchetti, Barbara Gripshover, Carl Grunfeld, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 3, 2006
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratumDonald P Kotler, Norma Muurahainen, Carl Grunfeld, et al.
AIDS (London, England)|December 5, 2015
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virusMelanie Thompson, Michael Saag, Edwin DeJesus, et al.
Plos One|January 14, 2020
Eligibility for hepatitis B antiviral therapy among adults in the general population in ZambiaMichael J Vinikoor, Edford Sinkala, Annie Kanunga, et al.
AIDS (London, England)|May 27, 2010
Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophyCarl Grunfeld, Michael Saag, Joseph Cofrancesco, et al.
AIDS Research and Human Retroviruses|February 16, 2006
Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophyJeffrey R Curtis, Barbara Smith, Michael Weaver, et al.
Pain Medicine (Malden, Mass.)|September 17, 2013
Low back pain and associated imaging findings among HIV-infected patients referred to an HIV/palliative care clinicElizabeth Molony, Andrew O Westfall, Brian A Perry, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Epidemiology (Cambridge, Mass.)|June 17, 2020
Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of DeathTiffany L Breger, Jessie K Edwards, Stephen R Cole, et al.
The Journal of Infectious Diseases|May 13, 2009
A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1Michael Saag, James Goodrich, Gerd Fätkenheuer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patientsDonald P Kotler, Norma Muurahainen, Carl Grunfeld, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Fat distribution in men with HIV infectionPeter Bacchetti, Barbara Gripshover, Carl Grunfeld, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 3, 2006
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratumDonald P Kotler, Norma Muurahainen, Carl Grunfeld, et al.
AIDS (London, England)|December 5, 2015
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virusMelanie Thompson, Michael Saag, Edwin DeJesus, et al.
Plos One|January 14, 2020
Eligibility for hepatitis B antiviral therapy among adults in the general population in ZambiaMichael J Vinikoor, Edford Sinkala, Annie Kanunga, et al.
AIDS (London, England)|May 27, 2010
Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophyCarl Grunfeld, Michael Saag, Joseph Cofrancesco, et al.
AIDS Research and Human Retroviruses|February 16, 2006
Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophyJeffrey R Curtis, Barbara Smith, Michael Weaver, et al.
Pain Medicine (Malden, Mass.)|September 17, 2013
Low back pain and associated imaging findings among HIV-infected patients referred to an HIV/palliative care clinicElizabeth Molony, Andrew O Westfall, Brian A Perry, et al.
Pageof 9